Greenfern Industries 命名为Kirsten Taylor董事会主席和Elizabeth Plant首席执行官,以推动药物大麻增长。 Greenfern Industries names Kirsten Taylor board chair and Elizabeth Plant CEO to drive medicinal cannabis growth.

Greenfern Industries,一家新西兰药用大麻公司,已任命Kirsten Taylor为新的董事会主席,Elizabeth Plant为首席执行官。 Greenfern Industries, a New Zealand medicinal cannabis company, has appointed Kirsten Taylor as its new board chair and Elizabeth Plant as CEO. Taylor带来了治理和产品创新方面的专门知识,而原为EQALIS制药公司首席医务干事的Plant具有广泛的保健经验。 Taylor brings expertise in governance and product innovation, while Plant, formerly Chief Medical Officer at EQALIS Pharmaceuticals, has extensive healthcare experience. 它们旨在扩大收入来源并开发创新的药用大麻产品。 They aim to expand revenue streams and develop innovative medicinal cannabis products.